These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 9426397
1. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants. Wellenreuther R, Waha A, Vogel Y, Lenartz D, Schramm J, Wiestler OD, von Deimling A. Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397 [Abstract] [Full Text] [Related]
4. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography. Kim JH, Kim IS, Kwon SY, Jang BC, Suh SI, Shin DH, Jeon CH, Son EI, Kim SP. Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152 [Abstract] [Full Text] [Related]
5. Expression of NF2 gene product merlin in arachnoid villi and meningiomas. Sakuda K, Kohda Y, Matsumoto T, Park C, Seto A, Tohma Y, Hasegawa M, Kida S, Nitta H, Yamashima T, Yamashita J. Noshuyo Byori; 1996 Nov; 13(2):145-8. PubMed ID: 8958521 [Abstract] [Full Text] [Related]
6. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas. Evans JJ, Jeun SS, Lee JH, Harwalkar JA, Shoshan Y, Cowell JK, Golubic M. J Neurosurg; 2001 Jan; 94(1):111-7. PubMed ID: 11147878 [Abstract] [Full Text] [Related]
7. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. Hansson CM, Buckley PG, Grigelioniene G, Piotrowski A, Hellström AR, Mantripragada K, Jarbo C, Mathiesen T, Dumanski JP. BMC Genomics; 2007 Jan 12; 8():16. PubMed ID: 17222329 [Abstract] [Full Text] [Related]
8. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjöld M, Collins VP. Nat Genet; 1994 Feb 12; 6(2):180-4. PubMed ID: 8162072 [Abstract] [Full Text] [Related]
9. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma. Nunes F, Shen Y, Niida Y, Beauchamp R, Stemmer-Rachamimov AO, Ramesh V, Gusella J, MacCollin M. Cancer Genet Cytogenet; 2005 Oct 15; 162(2):135-9. PubMed ID: 16213361 [Abstract] [Full Text] [Related]
10. NF2 status of meningiomas is associated with tumour localization and histology. Kros J, de Greve K, van Tilborg A, Hop W, Pieterman H, Avezaat C, Lekanne Dit Deprez R, Zwarthoff E. J Pathol; 2001 Jul 15; 194(3):367-72. PubMed ID: 11439370 [Abstract] [Full Text] [Related]
11. Merlin expression in secretory meningiomas: evidence of an NF2-independent pathogenesis? Immunohistochemical study. Buccoliero AM, Gheri CF, Castiglione F, Ammannati F, Gallina P, Taddei A, Garbini F, Rossi Degl'Innocenti D, Arganini L, Di Lorenzo N, Mennonna P, Taddei GL. Appl Immunohistochem Mol Morphol; 2007 Sep 15; 15(3):353-7. PubMed ID: 17721284 [Abstract] [Full Text] [Related]
12. Lack of genetic and epigenetic changes in meningiomas without NF2 loss. van Tilborg AA, Morolli B, Giphart-Gassler M, de Vries A, van Geenen DA, Lurkin I, Kros JM, Zwarthoff EC. J Pathol; 2006 Mar 15; 208(4):564-73. PubMed ID: 16353169 [Abstract] [Full Text] [Related]
13. Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization. Begnami MD, Rushing EJ, Santi M, Quezado M. Int J Surg Pathol; 2007 Apr 15; 15(2):110-5. PubMed ID: 17478763 [Abstract] [Full Text] [Related]
14. NF2 mutations in secretory and other rare variants of meningiomas. Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A. Brain Pathol; 2006 Jan 15; 16(1):15-9. PubMed ID: 16612978 [Abstract] [Full Text] [Related]
15. [Neurofibromatosis type 2 (NF2)]. Araki N, Takeshima H, Saya H. Gan To Kagaku Ryoho; 1997 Sep 15; 24(11):1427-31. PubMed ID: 9309136 [Abstract] [Full Text] [Related]
16. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases. Maxwell M, Shih SD, Galanopoulos T, Hedley-Whyte ET, Cosgrove GR. J Neurosurg; 1998 Mar 15; 88(3):562-9. PubMed ID: 9488313 [Abstract] [Full Text] [Related]
17. [A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma]. Sanson M. Rev Neurol (Paris); 1996 Jan 15; 152(1):1-10. PubMed ID: 8729390 [Abstract] [Full Text] [Related]